News

Industries

Companies

Jobs

Events

People

Video

Audio

Galleries

Submit content

My Account

Advertise with us

More...

Subscribe & Follow

Advertise your job vacancies
    Search jobs

    Drug Safety Africa 2018

    Hosted by the DST/NWU Preclinical Drug Development Platform (PCDDP)
    Drug Safety Africa 2018

    The DST/NWU Preclinical Drug Development Platform, supported by the North-West University and The Dept of Science and Technology, is proud to host the Drug Safety Africa 2018 conference and invites any individual in the academic or business environment with an interest in drug safety to register. At the Drug Safety Africa 2018 conference, models, methods, strategies and regulatory approaches to evaluate the preclinical and clinical safety of medicines, will be presented and discussed for the first time in Africa.

    Drug Safety Africa 2018
    Drug Safety Africa 2018

    More about the PCDDP

    Main topics

    At this conference, which takes place from 20 to 22 November 2018, on the Potchefstroom campus of the North-West University, the focus of lectures and discussions will be on four main topics: safety pharmacology, toxicology, clinical drug safety and precision medicine. Talks will include contributions from scientists, manufacturers, distributors and regulators involved in drug safety studies, who will discuss mutual new advances as well as challenges.

    Conference Programme

    Purpose of the conference

    The objectives of this conference are:

    1. to create a framework within which African scientists involved in the evaluation of safety pharmacology can meet and work with international experts to develop novel approaches to drug safety studies during the drug development process, and

    2. to establish a forum for interrogating and implementing new developments in safety pharmacology for both developers and regulators of new medicines.
    3. further, to provide a forum for identifying new partnerships and collaborations devoted to finding new, safe drugs to address unmet medical need in Africa and worldwide.
    4. to showcase newly established drug safety pharmacology infrastructure in southern Africa and to make efforts to identify shortcomings in expertise and infrastructure for addressing essential aspects of drug safety.
    5. to discuss career opportunities in drug safety will be discusse with pre- and post-doctoral students.

    Speakers

    Speakers represent academia as well as industry, both international and local and include the following:

    PCDDP, South Africa Convener
    Prof. Anne Grobler
    PCDDP, South Africa
    Convener
    Boehringer Ingelheim AG, Germany Convener
    Prof. Brian Guth
    Boehringer Ingelheim AG, Germany
    Convener
    Safety Pharmacology Society, USA
    Dr Michael Pugsley
    Safety Pharmacology Society, USA
    MRC Harwell (MPC), UK
    Dr Sarah Wells
    MRC Harwell (MPC), UK
    University of Pretoria, South Africa
    Prof. Mike Sathekge
    University of Pretoria, South Africa
    Roche, Switzerland
    Dr Andrea Greiter-Wilke
    Roche, Switzerland
    GlaxoSmithKline
    Dr Kendall Frazier
    GlaxoSmithKline
    Infrafrontier GmbH
    Dr Asrar Ali Kahn
    Infrafrontier GmbH
    The Jackson Laboratory, USA
    Dr Karen Svenson
    The Jackson Laboratory, USA
    Maastricht University, the Netherlands
    Prof. Harry Steinbusch
    Maastricht University, the Netherlands
    Novo Nordisk, Denmark
    Dr Tomas Mow
    Novo Nordisk, Denmark

    Call for abstracts

    Students and scientists are invited to submit abstracts on the main topics, which, if accepted will be presented as a poster presentation for the duration of the conference and will also feature in the abstract book.

    Register here to attend this conference.

    Drug Safety Africa 2018


    Related
    More news
    Let's do Biz